CAS 76470-15-0: Kaur-16-en-15-one,7,20-epoxy-1,6,7,11-tetrahydroxy-, (1a,6b,7a,11a)-

Effusanin E inhibits bacterial growth, counters cancer by blocking p50/p65 and reducing COX-2, halting NPC cell proliferation and triggering cell death.

Effusanin E is a specialized natural compound that falls under the category of secondary metabolites. It is derived from microorganisms, specifically isolated from bacterial sources, which include soil-dwelling bacteria known for their unique biosynthetic capabilities. This compound's mode of action primarily involves inhibiting the growth of certain pathogenic bacteria. It achieves this by disrupting vital bacterial processes, potentially targeting aspects of cell wall synthesis or protein production, although the exact mechanisms may vary and require further elucidation. Effusanin E has garnered significant interest in scientific research, primarily due to its potential applications in the field of antimicrobial drug development. It serves as a promising candidate for exploring new antibiotic therapies, especially in the context of rising antibiotic resistance. Its structural complexity and unique biological activities make it a subject of intense study, as researchers aim to characterize its bioactivity and assess its efficacy against resistant bacterial strains. Continued research may reveal novel therapeutic pathways and further applications in medical and pharmaceutical fields.